CytomX Therapeutics
CTMX
#8677
Rank
NZ$0.15 B
Marketcap
$1.96
Share price
1.25%
Change (1 day)
-8.73%
Change (1 year)

Market capitalization of CytomX Therapeutics (CTMX)

Market cap: NZ$0.15 Billion

As of September 2024 CytomX Therapeutics has a market cap of NZ$0.15 Billion. This makes CytomX Therapeutics the world's 8677th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CytomX Therapeutics from 2015 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$0.15 B-6.56%
2023NZ$0.16 B-1.41%
2022NZ$0.16 B-59.63%
2021NZ$0.41 B-6.12%
2020NZ$0.43 B-21.64%
2019NZ$0.56 B-44.72%
2018NZ$1.01 B-11.15%
2017NZ$1.14 B97.67%
2016NZ$0.57 B-47.5%
2015NZ$1.10 B

End of Day market cap according to different sources

On Sep 29th, 2024 the market cap of CytomX Therapeutics was reported to be:

NZ$0.15 Billion
by Yahoo Finance info icon info icon
NZ$0.15 Billion
by CompaniesMarketCap info icon info icon
NZ$0.15 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$1.15 B 655.87%๐Ÿ‡บ๐Ÿ‡ธ USA